Tillement, Olivier

Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)

Verry, C., Dufort, S., Villa, J., Gavard, M., Iriart, C., Grand, S., Charles, J., Chovelon, B., Cracowski, J.-L., Quesada, J.-L., et al. (2021) · Radiotherapy and Oncology

Brain Metastases and TreatmentRadiation Therapy and Dosimetry

Cited by 173

AGuIX nanoparticles enhance ionizing radiation-induced ferroptosis on tumor cells by targeting the NRF2-GPX4 signaling pathway

Sun, H., Cai, H., Xu, C., Zhai, H., Lux, F., Xie, Y., Feng, L., Du, L., Liu, Y., Sun, X., et al. (2022) · Journal of Nanobiotechnology

Radiation Therapy and DosimetryFerroptosis and cancer prognosis

Cited by 86

Quantifying nanotherapeutic penetration using a hydrogel-based microsystem as a new 3D in vitro platform

Goodarzi, S., Prunet, A., Rossetti, F., Bort, G., Tillement, O., Porcel, E., Lacombe, S., Wu, T.-D., Guerquin-Kern, J.-L., Delanoë-Ayari, H., et al. (2021) · Lab on a Chip

3D Printing in Biomedical ResearchNanoparticle-Based Drug Delivery

Cited by 29

Anti-MUC1-C Antibody-Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation Therapy

Detappe, A., Mathieu, C., Jin, C., Agius, M. P., Diringer, M.-C., Tran, V.-L., Pivot, X., Lux, F., Tillement, O., Kufe, D., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics

Radiation Therapy and DosimetryRadiopharmaceutical Chemistry and Applications

Cited by 27